Cargando…

Progress in novel cognitive enhancers for cognitive aging and Alzheimer’s disease

Increased knowledge of the biology of synaptic function has led to the development of novel cognitive-enhancing therapeutic strategies with the potential for increased efficacy and safety. This editorial highlights a diverse array of approaches currently being explored to target cognitive dysfunctio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shineman, Diana W, Carman, Aaron J, Dacks, Penny A, Lane, Rachel F, Fillit, Howard M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979029/ https://www.ncbi.nlm.nih.gov/pubmed/24083622 http://dx.doi.org/10.1186/alzrt209

Ejemplares similares

Diverse therapeutic targets and biomarkers for Alzheimer's disease and related dementias: report on the Alzheimer's Drug Discovery Foundation 2012 International Conference on Alzheimer's Drug Discovery
por: Lane, Rachel F, et al.
Publicado: (2013)

Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
por: Friedman, Lauren G, et al.
Publicado: (2014)

Beyond amyloid: a diverse portfolio of novel drug discovery programs for Alzheimer's disease and related dementias
por: Lane, Rachel F, et al.
Publicado: (2011)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA
por: Lee, Linda H, et al.
Publicado: (2010)

Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline
por: Dacks, Penny A., et al.
Publicado: (2016)

Translating the biology of aging into novel therapeutics for Alzheimer disease
por: Hara, Yuko, et al.
Publicado: (2019)

Cognitive reserve, neuropathology, and progression towards Alzheimer’s disease
por: Nelson, Monica E., et al.
Publicado: (2023)

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia
por: Matthews, Dawn C., et al.
Publicado: (2021)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

Cognitive training and neuromodulation for Alzheimer treatment
por: Vecchio, Fabrizio
Publicado: (2022)

New Trends in Cognitive Aging and Mild Cognitive Impairment
por: Facal, David, et al.
Publicado: (2022)

Getting smart to cognitive enhancers
Publicado: (2019)

A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease
por: Chen, Qi, et al.
Publicado: (2011)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)

The Cognitive Neurology of Bilingualism in the Age of Globalization
por: Abutalebi, Jubin, et al.
Publicado: (2014)

THC for age-related cognitive decline?
por: Sarne, Yosef
Publicado: (2018)

Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan
por: Osone, Akira, et al.
Publicado: (2015)

Neuroplastic Mechanisms Underlying Perceptual and Cognitive Enhancement
por: de Villers-Sidani, Etienne, et al.
Publicado: (2016)

Editorial: Five Years of Journal of Cognitive Enhancement
por: Colzato, Lorenza S.
Publicado: (2022)

Cognitive aging and dementia prevention: the time for psychology?
por: Bartrés-Faz, David, et al.
Publicado: (2023)

Body Mass Index in Mild Cognitive Impairment According to Age, Sex, Cognitive Intervention, and Hypertension and Risk of Progression to Alzheimer's Disease
por: Joo, Soo Hyun, et al.
Publicado: (2018)

Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
por: McGrattan, Andrea M., et al.
Publicado: (2019)

Using machine learning to extract cognitive status from the sleep EEG in progressing stages of dementia: defining interpretable and age-related features
por: Kam, Korey, et al.
Publicado: (2022)

Novel lacto-peptides improve cognitive decline
por: Ano, Yasuhisa, et al.
Publicado: (2019)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
por: Wallin, Anders, et al.
Publicado: (2022)

A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study
por: Jutten, Roos J., et al.
Publicado: (2017)

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
por: Shineman, Diana W, et al.
Publicado: (2011)

Detection of Alzheimer’s Disease-Related Cognitive Change With the Mobile Cognitive App Performance Platform
por: Mechanic-Hamilton, Dawn, et al.
Publicado: (2020)

Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's disease
por: Hendrix, Suzanne B, et al.
Publicado: (2013)

Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
por: Tatsuoka, Curtis, et al.
Publicado: (2013)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

Neurological Soft Signs in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease – The Impact of Cognitive Decline and Cognitive Reserve
por: Urbanowitsch, Nadja, et al.
Publicado: (2015)

Occupational activity and cognitive reserve: implications in terms of prevention of cognitive aging and Alzheimer’s disease
por: Adam, Stéphane, et al.
Publicado: (2013)

Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments
por: Hake, Ann M., et al.
Publicado: (2017)

Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
por: Shim, Yong S., et al.
Publicado: (2011)

Does Informant-Based Reporting of Cognitive Decline Correlate with Age-Adjusted Hippocampal Volume in Mild Cognitive Impairment and Alzheimer’s Disease?
por: Sabbagh, Marwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or4an7o6q05pg653v2lc6fdrao